News Focus
News Focus
Followers 134
Posts 2185
Boards Moderated 0
Alias Born 11/22/2017

Re: Lykiri post# 741315

Wednesday, 01/01/2025 7:38:39 PM

Wednesday, January 01, 2025 7:38:39 PM

Post# of 817828

It wasn’t an easy task, but I concluded that there were probably 3 or 4.



Here is medicine number 4, approved by MHRA on 31 December 2024.

Tarlatamab approved to treat adult patients with small cell lung cancer.

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 31 December 2024, approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung cancer (SCLC) that has spread throughout the lungs and/or to other parts of the body.


https://www.gov.uk/government/news/tarlatamab-approved-to-treat-adult-patients-with-small-cell-lung-cancer

This medicine had its first CHM meeting on 2/22/24.

a medicine used to treat adult patients with small cell lung cancer that has spread
throughout the lungs and/or to other parts of the body and where treatment with
chemotherapy that contains platinum did not work or is no longer working.


https://app.box.com/s/jv487awvqzzsrdql0o34h9gg350ceyd4/file/1722451876042
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News